Risk of covid-19 related death and hospital ad... - CLL Support

CLL Support

22,514 members38,671 posts

Risk of covid-19 related death and hospital admission after covid-19 vaccination

bennevisplace profile image
11 Replies

An enormous prospective cohort study in vaccinated UK adults, producing hazard ratios for many different population groups.

Blood cancer patients do surprisingly well compared with other at-risk groups.

bmj.com/content/374/bmj.n2244

Written by
bennevisplace profile image
bennevisplace
To view profiles and participate in discussions please or .
Read more about...
11 Replies
AussieNeil profile image
AussieNeilAdministrator

Noted 3 days earlier in an addition to the COVID-19 Mythbuster post. COVID-19 vaccinations do work and rather well at that!

healthunlocked.com/cllsuppo...

chillsome profile image
chillsome

This is great news! Thanks

bennevisplace profile image
bennevisplace in reply to chillsome

It does show that vaccines have been generally highly effective, but the modest hazard ratio for blood cancer patients is not a licence to relax and drop your guard, see other comments here.

chillsome profile image
chillsome in reply to bennevisplace

Yes that's true and also in reading the data we have to take into account that, as a group, we are probably being more careful than the general population.

Art3mis1 profile image
Art3mis1

I’ll be very interested to see the full, peer reviewed report to understand how it dealt with the human factors in the data. Most extremely clinically vulnerable people in the UK were wisely shielding during this time, so transmission, even post vaccination, would have been affected by the this factor. If they weren’t ‘out in society’ mingling, the risk to the ECV group was lower (they were basically isolating). I know that this detail probably won’t have been captured in the data made available to the study, but I hope that it notes and caveats the limitations of the findings.

The reason I am raising this, is in a consultants letter in April ‘21 from my Mums consultant to her GP he highlighted that she ‘hadn’t taken any antibiotics or had any infections’ in the preceding 12 months - very rare as this included the winter months, and indeed factually correct. BUT OUT OF CONTEXT as not so rare, as she’d been shielding and haven’t mixed with society for 12 months! The GP has used this information, to discount concerns about her CLL (“she is clearly much better”) and the risk from COVID citing that she has been infection free from Nov 20 - Apr 21. But this was because she was shut in the house with no visitors for pretty much all of this time! Grrrrrrrr

Psmithuk profile image
Psmithuk in reply to Art3mis1

I wonder if this is why the governments think we are safe enough not to need the shielding we have been following. It’s been on my mind for a while - of course we are less likely to catch Covid when we don’t see anyone, and keep away from shops and indoor meetings!Cx

bennevisplace profile image
bennevisplace in reply to Psmithuk

Yep.

bennevisplace profile image
bennevisplace in reply to Art3mis1

I believe this is all we're going to get by way of peer reviewed report, From the footnotes:

The lead author affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.

Dissemination to participants and related patient and public communities: Patients will be invited to advise on disseminating the results.

Provenance and peer review: Not commissioned; externally peer reviewed.

You make a good point about shielding probably having lowered the relative risk of the blood cancer cohort. It's stated in the Introduction, and bears repeating here:

"The risk of a severe outcome in vaccinated groups includes the risk of exposure, the risk of a breakthrough infection if exposed, and the risk of a breakthrough infection becoming severe".

Post vaccination, we are at increased risk if we fail to manage our risk of exposure.

Pinkdark2018 profile image
Pinkdark2018

This study covered a period when lockdowns were in place and fails to take into account the groups who were shielding effectively, including blood cancer patients. Also, analysis only includes 4 deaths in people who had received both doses so has little relationship to the current situation. Infection rates now are higher than for most of the period covered and protective behaviour has been completely abandoned so the risks currently are completely different. It is also worth mentioning that they state blood cancer not individual subsets of blood cancer.

bennevisplace profile image
bennevisplace in reply to Pinkdark2018

Valid points.

stewie profile image
stewie

I agree we still need to be careful but it's so much better than a year ago , vaccines which may give some of us some protection or make the disease less severe , different treatments now on offer and the new antiviral drug being approved , I'm working in the NHS client/patient facing role ,so difficult for me to be really careful All the best

Stewie

You may also like...

COVID-19 hospitalizations soaring in England.

Stopping Venetoclax for COVID-19 vaccine

before and after administration of the Covid -19 vaccine?

Combining the Influenza and COVID-19 vaccines.

clinical trial, the vaccine candidates were compared to a licensed influenza vaccine and the...

U.S. advisory group lays out detailed recommendations on how to prioritize Covid-19 vaccine

Covid-19 vaccine and focuses on who is at risk, rather than using job categories or ethnic groups...

Covid Vaccine after obinutuzumab

to take the vaccine, or if there is a test he can do to detect his readiness for the vaccine